REC-3565 An investigational MALT1 inhibitor in Phase 1 development for B-cell malignancies, designed for selective target inhibition.
Visit productCosigns Received
Be the first Cosign
Put your name behind REC-3565.
Add it to your Products I use list and share why you use it.